Survival analysis of sirolimus-based immunosuppression in liver transplantation in patients with hepatocellular carcinoma.

MLA

Xu, Shi-Lei, et al. “Survival Analysis of Sirolimus-Based Immunosuppression in Liver Transplantation in Patients with Hepatocellular Carcinoma.” Clinics and Research in Hepatology and Gastroenterology, vol. 40, no. 6, Dec. 2016, pp. 674–81. EBSCOhost, https://doi.org/10.1016/j.clinre.2016.03.006.

APA

Xu, S.-L., Zhang, Y.-C., Wang, G.-Y., Yang, Q., Liu, B., Zhang, J., Li, H., Wang, G.-S., Yang, Y., & Chen, G.-H. (2016). Survival analysis of sirolimus-based immunosuppression in liver transplantation in patients with hepatocellular carcinoma. Clinics and Research in Hepatology and Gastroenterology, 40(6), 674–681. https://doi.org/10.1016/j.clinre.2016.03.006

Chicago

Xu, Shi-Lei, Ying-Cai Zhang, Guo-Ying Wang, Qing Yang, Bo Liu, Jian Zhang, Hua Li, Gen-Shu Wang, Yang Yang, and Gui-Hua Chen. 2016. “Survival Analysis of Sirolimus-Based Immunosuppression in Liver Transplantation in Patients with Hepatocellular Carcinoma.” Clinics and Research in Hepatology and Gastroenterology 40 (6): 674–81. doi:10.1016/j.clinre.2016.03.006.